[FATE] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
01-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -10.77%
YoY- -22.28%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 1,027 1,026 1,027 1,026 1,026 1,027 1,027 0.00%
PBT -19,654 -14,135 -12,497 -10,684 -9,645 -10,126 -7,940 83.29%
Tax 376 331 -131 378 137 111 -160 -
NP -19,654 -14,135 -12,497 -10,684 -9,645 -10,126 -7,940 83.29%
Tax Rate - - - - - - - -
Total Cost 20,681 15,161 13,524 11,710 10,671 11,153 8,967 74.82%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -1,913.73 -1,377.68 -1,216.85 -1,041.33 -940.06 -985.98 -773.13 83.29%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.37 -0.27 -0.29 -0.26 -0.23 -0.24 -0.21 46.02%
EPS Diluted -0.37 -0.27 -0.29 -0.26 -0.23 -0.24 -0.21 46.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.